MedTrace Logo

Weight-Adjusted Dosing of 3-OHB in Patients With Chronic Heart Failure

NCT04594265 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2022-07-18

No results posted yet for this study

Summary

We aim to investigate the hemodynamic effects of weight-adjusted dosing of ketone monoester en patients with chronic heart failure.

Conditions

Interventions

DIETARY_SUPPLEMENT

KetoneAid KE4 Pro Monoester

A dietary supplement containing ketone monoester.

DIETARY_SUPPLEMENT

Science in Sport Go Enegy

Dosis isocaloric to the KetoneAid Arm

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04594265 on ClinicalTrials.gov